How to Analyse Hims & Hers Stock Before Investing in 2025


Telehealth platform offering prescription and non-prescription wellness products in the US, UK, and globally.

Strong Revenue Growth Strong Revenue Growth Q2 2025 revenue rose 73% year-over-year to $544.8M. Subscriber base up 31% to 2.4 million. Q2 2025 revenue rose 73% year-over-year to $544.8M. Subscriber base up 31% to 2.4 million.

Stock Performance 2025 stock price range: $13.47 – $72.98. Current price around $51.94 with a market cap of $11.7B. Stock Performance 2025 stock price range: $13.47 – $72.98. Current price around $51.94 with a market cap of $11.7B. Stock Performance Stock Performance

[{"selector":"#anim-98308832-8bee-4c99-a7f0-8f32d562778a","keyframes":{"opacity":[0,1]},"delay":0,"duration":2000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-70cfb805-fec1-47d7-b696-a7f2e6b550fd","keyframes":{"transform":["translate3d(100%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Opportunities: Diversification, international expansion, subscription model. Opportunities: Diversification, international expansion, subscription model. Opportunities and Risks Opportunities and Risks

Hims & Hers is growing fast in telehealth but faces volatility. Hims & Hers is growing fast in telehealth but faces volatility. Investor Takeaway Investor Takeaway

Telehealth platform offering prescription and non-prescription wellness products in the US, UK, and globally.

Hims & Hers Health Overview